dienogest has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, T; Harada, M; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Miyashita, M; Nagai, M; Osuga, Y; Takamura, M | 1 |
| Katsuki, Y; Nakamura, M; Oikawa, T; Shibutani, Y | 1 |
2 other study(ies) available for dienogest and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Aromatase; Case-Control Studies; Cell Proliferation; Endometriosis; Female; Humans; In Situ Nick-End Labeling; Ki-67 Antigen; Nandrolone; Neovascularization, Pathologic; von Willebrand Factor | 2014 |
Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Cell Division; Chorion; Depression, Chemical; Embryo, Mammalian; Endothelium, Vascular; Female; Mice; Mice, Inbred ICR; Microcirculation; Nandrolone; Neovascularization, Pathologic; Neovascularization, Physiologic; Plasminogen Activators; Regional Blood Flow; Tumor Cells, Cultured | 1999 |